The advent of automated in vitro screening of hundreds of thousands of compounds has introduced biases into the drug discovery process that have significant implications for subsequent drug development. Screening biases that impact oral absorption adversely are discussed, and approaches are suggested for the prediction, assessment and communication of absorption-related physical chemical properties in drug discovery and exploratory development.